Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
Holding STAA?
Track your performance easily
STAA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.88 - $52.68
Previous Close$26.68
Volume527.87K
Average Volume (3M)729.46K
Market Cap
$1.31B
Enterprise Value$1.12B
Total Cash (Recent Filing)$235.96M
Total Debt (Recent Filing)$40.00M
Price to Earnings (P/E)60.9
Beta1.40
Next Earnings
Feb 19, 2025EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.44
Shares Outstanding49,275,875
10 Day Avg. Volume680,077
30 Day Avg. Volume729,458
Standard Deviation0.18
R-Squared0.03
Alpha0.00584
Financial Highlights & Ratios
Price to Book (P/B)3.03
Price to Sales (P/S)3.77
Price to Cash Flow (P/CF)84.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.28
Enterprise Value/Gross Profit4.43
Enterprise Value/Ebitda44.06
Forecast
1Y Price Target
$37.00Price Target Upside38.68% Upside
Rating ConsensusHold
Number of Analyst Covering8
Staar Surgical News
PremiumCompany Announcements
STAAR Surgical Posts Strong Q3 2024 Financial Results
PremiumCompany Announcements
Staar Surgical Achieves 10% Sales Growth, Income Doubles
Bulls Say, Bears Say
Bulls Say
Financial GuidanceDespite the challenges in key markets, full-year 2024 top-line guidance was maintained at $340-345mn on outlook of continued global adoption and share gains.
Operating PerformanceSTAA showed better than expected operating margin leverage.
ValuationValuation remains heavily discounted with the stock now trading nearly -2SD below the 5-year historical average multiple.
Bears Say
Consumer DemandSoft ophthalmic procedure demand and a weaker consumer in China could lead to downside to STAA's estimates over the next 12-18 months.
Growth ExpectationsManagement reduced the guidance related to both China and US growth expectations.
Market ChallengesThe US refractive market was much more challenging than expected.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $25.88 and its highest was $52.68 in the past 12 months.
What is Staar Surgical’s market cap?
Currently, no data Available
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Feb 19, 2025 which is in 85 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Oct 30, 2024. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.08.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is -$0.03.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,275,875 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of $0.26 in its last earnings report, beating expectations of $0.18. Following the earnings report the stock price went down -1.695%.
Which hedge fund is a major shareholder of Staar Surgical?
Among the largest hedge funds holding Staar Surgical’s share is Defender Capital, LLC.. It holds Staar Surgical’s shares valued at 25M.
---
Staar Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$37.00 (38.68% Upside)
$37.00 (38.68% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 83%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 28.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.85%
12-Months-Change
Fundamentals
Return on Equity
5.40%
Trailing 12-Months
Asset Growth
14.01%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
---
STAA Earnings Call
Q3 2024
0:00 / 0:00
---
STAA Stock 12 Month Forecast
Average Price Target
$37.00
▲(38.68% Upside)
Technical Analysis
Best Analysts Covering STAA
1 Year
1 Year Success Rate
4/11 ratings generated profit
1 Year Average Return
-2.03%
reiterated a buy rating 22 days ago
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -2.03% per trade.
---